Versions Compared

Version Old Version 1573 New Version 1574
Changes made by

Nicola Newton

Nicola Newton

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Real World Data Autumn Event – Call For Speakers

We’re excited to announce Call for Speakers for the Real World Evidence Working Group’s second multi‑day virtual event is now open! Taking place 30 September – 1 October 2026, from 09:00–11:30 (EDT) / 14:00–16:30 (BST) / 15:00–17:30 (CEST).

Submit your abstract by 8 May for the chance to present.

Focus your submission on these central themes:

  • Optimising the Generation of Real‑World Evidence with NLP & AI

  • Digital Endpoints Generated from Real‑World Data

  • Data Sources, Lineage and Provenance

  • Vendor–Sponsor Governance and Alignment

  • Any Other Theme that Tackles the Challenges in Using Real‑World Data

Click here for more information.

Info

Submit Abstract Here

...

Framework for Integrating Omics Data with Other Clinical and Non-Clinical Data SourcesEmerging Trends & Innovation – Calling For Feedback

The Integration of Omics Data into Clinical Drug Development project within the Emerging Trends & Innovation Working Group has published a new white paper, Framework for Integrating Omics Data with Other Clinical and Non-Clinical Data Sourceswhich is now open for public review.

This white paper proposes a framework for integrating multi-omics data with clinical and non-clinical datasets, combining BioCompute for workflow documentation and MultiAssayExperiment (MAE) for data management. It aims to improve standardisation, interoperability, and reproducibility to better support personalised medicine and regulatory use. 

The team welcome feedback on the paper by 31 March . Please send responses to workinggroups@phuse.global.

Real World Evidence – Calling For Feedback

The Quality and Reusability of Real World Data Project within the Real World EvidenceWorking Group has produced a White Paper ‘Real-World Data Reliability and Integrity: Ensuring Real-World Data is Fit for Use for Regulatory Submissions’. This White Paper focuses on the usability of real-world data sources for regulatory submission purposes. To assess the fit for use of this data, we need to assess the relevance and the reliability of the data.

Please provide your comments by emailing workinggroups@phuse.global. Closing date for comments: 24 April 2026.

...

PharmaForest: A Collaborative Repository of SAS Packages for Pharmaceutical Industry project team within the Data Visualisation & Open Source Technology Working Group, is calling for volunteers!

PharmaForest is a collaborative initiative focused on improving how SAS programming is developed and shared across the pharmaceutical industry. Built on the SAS Packages Framework (SPF), it promotes reusable, standardised SAS packages to reduce duplication, improve efficiency, and support compliance.

By combining an open package repository with community collaboration and practical guidance, PharmaForest helps move SAS programming from siloed approaches to a more scalable, industry-wide model.

If you’d like to become a valued project member, please get in touch with workinggroups@phuse.global.

...